-+ 0.00%
-+ 0.00%
-+ 0.00%

Roivant Sciences President and Immunovant CEO Eric Venker sells $7.26 million in Roivant common shares

PUBT·11/05/2026 23:53:53
Listen to the news
Roivant Sciences President and Immunovant CEO Eric Venker sells $7.26 million in Roivant common shares
  • Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on Nov. 3, 2026.
  • The Nov. 5, 2026, filing reported a $36.31 sale price, leaving Venker with 999,154 directly held common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001635088-26-000123), on November 05, 2026, and is solely responsible for the information contained therein.